Software that uses artificial intelligence to flag and triage cases of pulmonary embolism found in chest CT scans has been cleared by the FDA, Israeli radiology AI company Aidoc announced on May 15.
The module analyzes imaging data immediately after the scan is complete and can identify signs of a potentially life-threatening pulmonary embolism within five minutes, a time-sensitive diagnosis that often takes expert radiologists several hours to determine.
This is the second FDA-cleared AI-powered radiology solution for Aidoc, which received approval in August 2018 for a system using deep learning to flag cases of acute intracranial hemorrhage in head CT scans.
More articles about AI:
3 new AI-enabled FDA 'Breakthrough Devices': an Alzheimer's-detecting retinal scanner, a kidney disease diagnostic & more
Deep learning system detects ACL tears as accurately as trained radiologists
NIH gives biotech company $300K to use AI to develop hantavirus antibodies